A strong commitment to sharing clinical trial results is important for medical progress

Novo Nordisk is committed to sharing information about all clinical studies and their results, irrespective if these are positive or negative. This is because important contributions to overall medical progress and general medical understanding are made by enabling access to trial information for researchers, participants in trials, and anyone else who may be interested.

Information about clinical trials is shared in several ways. At the beginning of a clinical trial, information is posted in relevant public registries. When the trial has ended, the goal is to publish the key conclusions in scientific journals. The results are communicated further by including them in applicable registries and on this website in the form of summaries in layperson language and clinical study reports. In addition, researchers can request access to detailed clinical trial data, which they can explore for their own research purposes. All information communicated and shared on clinical studies is de-identified.

See below for more details on how clinical trial data are shared.

Search published results of 
 clinical trials

Search published results of clinical trials

View results
Search published results of 
 clinical trials

Search published results of clinical trials

View results